Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04212650 · ClinicalTrials.gov registry record · Phase 1
Losartan to Improve Hip Microfracture
A Phase 1 study, sponsored by Steadman Philippon Research Institute.
- Terminated
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
NCT04212650 is a Phase 1 study that was terminated before completion, run by Steadman Philippon Research Institute. The registered enrollment target is 1 participants.
The verdict
NCT04212650, a Phase 1 study, was terminated before completion, sponsored by Steadman Philippon Research Institute.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
Phase I/IIA randomized, double-blind, placebo-controlled clinical trial to assess safety and efficacy of oral losartan for improving cartilage repair following microfracture to treat focal cartilage defects during hip arthroscopy.
Interventions
- OTHER Placebo
- DRUG Losartan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2020-08-07 |
| Est. Completion | 2020-12-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04212650
The ClinicalTrials.gov registry entry for NCT04212650 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Steadman Philippon Research Institute, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04212650 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04212650 about?
NCT04212650 is a clinical study titled "Losartan to Improve Hip Microfracture". Phase I/IIA randomized, double-blind, placebo-controlled clinical trial to assess safety and efficacy of oral losartan for improving cartilage repair following microfracture to treat focal cartilage defects during hip arthroscopy.
What is the current status of trial NCT04212650?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2020-08-07. Estimated completion is 2020-12-04.
What interventions are being tested in trial NCT04212650?
The interventions under investigation include: Placebo (OTHER), Losartan (DRUG).
Who is sponsoring clinical trial NCT04212650?
This trial is sponsored by Steadman Philippon Research Institute, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.